公开(公告)号：US12128028B2

公开(公告)日：2024-10-29

申请号：US17258273

申请日：2019-07-05

Applicant: METRION BIOSCIENCES LIMITED

Inventor： Marc Rogers ,  Robert Kirby ,  Gakujun Shomi ,  Takuya Matsuo ,  Satoru Kobayashi ,  Junichiro Kanazawa ,  Nobutaka Yamaoka ,  Makoto Torizuka ,  Koichi Suzawa

IPC: A61K31/4164 ,  A61K31/4178 ,  A61K31/439 ,  A61K31/4439 ,  A61K31/454 ,  A61K31/46 ,  A61K31/5377 ,  A61K31/55 ,  C07D233/28 ,  C07D235/02 ,  C07D401/06 ,  C07D401/12 ,  C07D403/06 ,  C07D403/12 ,  C07D405/12 ,  C07D409/12 ,  C07D471/08 ,  C07D491/107

CPC classification number: A61K31/4164 ,  A61K31/4178 ,  A61K31/439 ,  A61K31/4439 ,  A61K31/454 ,  A61K31/46 ,  A61K31/5377 ,  A61K31/55 ,  C07D233/28 ,  C07D235/02 ,  C07D401/06 ,  C07D401/12 ,  C07D403/06 ,  C07D403/12 ,  C07D405/12 ,  C07D409/12 ,  C07D471/08 ,  C07D491/107

Abstract: The invention relates to heterocyclic sulfonamide derivatives and their use in the treatment and prophylaxis of autoimmune, inflammatory, cardiovascular, neuronal, auditory, renal and metabolic mediated diseases, and to compositions containing said derivatives and processes for their preparation.